Free CE/CME Activities

Browse free continuing education activities across medical specialties

Mechanism Matters—How OTC Therapies Interrupt the Allergic CascadeFree CE/CME

Mechanism Matters—How OTC Therapies Interrupt the Allergic Cascade

Ophthalmology, Optometry

Available through July 1, 2027

Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO

CMECOPE
Burst CME™ Part VI: What Does this all Mean for Patients with IgAN?Free CE/CME

Burst CME™ Part VI: What Does this all Mean for Patients with IgAN?

Nephrology

Available through July 1, 2027

Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD

CME
Burst CME™ Part V: Complement Inhibitors in IgANFree CE/CME

Burst CME™ Part V: Complement Inhibitors in IgAN

Nephrology

Available through July 1, 2027

Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD

CME
Burst CME™ Part IV: Anti-CD38 Therapies in IgANFree CE/CME

Burst CME™ Part IV: Anti-CD38 Therapies in IgAN

Nephrology

Available through July 1, 2027

Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD

CME
Burst CME™ Part III: BAFF and APRIL Directed Therapies in IgANFree CE/CME

Burst CME™ Part III: BAFF and APRIL Directed Therapies in IgAN

Nephrology

Available through July 1, 2027

Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD

CME
Burst CME™ Part II: Endothelin A Receptor Antagonists in IgANFree CE/CME

Burst CME™ Part II: Endothelin A Receptor Antagonists in IgAN

Nephrology

Available through July 1, 2027

Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD

CME
Burst CME™ Part I: What’s New in IgAN?Free CE/CME

Burst CME™ Part I: What’s New in IgAN?

Nephrology

Available through July 1, 2027

Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD

CME
Burst CME™: Elevating Care in the Management of IgA Nephropathy (IgAN) Nursing TrackFree CE/CME

Burst CME™: Elevating Care in the Management of IgA Nephropathy (IgAN) Nursing Track

Nephrology

Available through July 1, 2027

Professor Jonathan Barratt, PhD, FRCP; Richard Lafayette, MD

NCPD
Advances in™ Generalized Myasthenia Gravis: Continuing the Quest for Novel TherapiesFree CE/CME

Advances in™ Generalized Myasthenia Gravis: Continuing the Quest for Novel Therapies

Neurology

Available through July 1, 2027

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

CME
Cases and Conversations™: Uniting Heart and Kidney Care: Optimizing Outcomes in Cardio-Kidney-Metabolic DisordersFree CE/CME

Cases and Conversations™: Uniting Heart and Kidney Care: Optimizing Outcomes in Cardio-Kidney-Metabolic Disorders

Cardiology, Endocrinology, Diabetes & Metabolism, Nephrology, Primary Care

Available through July 1, 2027

Katherine E. Di Palo, PharmD, MBA, MS; Nancy M. Albert, PhD, APRN-CCNS, CHFN, CCRN, NE-BC, FCCM, FAHA, FHFSA, FAAN; Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert

CMENCPD
Beyond the Itch—Decoding the Immunopathology of Allergic Conjunctivitis Free CE/CME

Beyond the Itch—Decoding the Immunopathology of Allergic Conjunctivitis

Ophthalmology, Optometry

Available through July 1, 2027

Walter Whitley, OD, MBA, FAAO; Cecelia Koetting, OD, FAAO, DipABO

CMECOPE
Modality Matters—Optimizing Contact Lens Selection for Real-World WearFree CE/CME

Modality Matters—Optimizing Contact Lens Selection for Real-World Wear

Ophthalmology, Optometry

Available through July 1, 2027

Adam Ramsey, OD; Jessilin Quint, OD, MBA, MS, FAAO

CMECOPE